Abstract:Objective:To evaluate the bioequivalence of domestic and imported fluoxetine capsules in the healthy volunteers.Methods:A single oral dosage of 40 mg test or reference preparations of fluoxetine was given to 22 healthy volunteers in a randomized crossover study.The fluoxetine concentrations in serum were determined by HPLC-MS assay.The pharmacokinetic parameters and relative bioavailability were calculated to evaluate the bio- equivalence of two preparations.Results:The main phamacokinetic parameters of the reference and test products were as follows:t_(max)(7.41±1.74) h and (7.36±1.87) h;C_(max)(43.64±11.10) ng·mL~(-1)and(44.90±11.39) ng· mL~(-1);AUC_(0～tn)(2817.7±927.5) ng·h·mL~(-1)and (2870.5±989.8)ng·h·mL~(-1);AUC_(0～∞)(2847.4± 952.9)ng·h·mL~(-1)and (2892.0±1012.0) ng·h·mL~(-1);t_((1/2)(ke))(73.63±16.89) h and(69.37±13.05) h; K_e(0.0099±0.0025)h~(-1)and (0.0104±0.0023)h~(-1),respectively.The relative bioavailability was(101.74± 12.44) %.Conclusion:The variance analysis and two one side tests show that the two preparations are bioequiva- lent.

Bioequivalence study of fluoxetine capsules in healthy volunteers